跳至主要内容
临床试验/NL-OMON55652
NL-OMON55652已完成不适用

Multi-Center Clinical Evaluation of the ATTUNE® Revision System in Revision Total Knee Arthroplasty - DSJ-2016-02: Attune revision

Cturn0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Subject is male or female and between the ages of 22 and 80 years at the time
  • of consent, inclusive.
  • * Subject presents with a primary knee arthroplasty (primary TKA,
  • unicompartmental) or prior revision TKA that requires a revision procedure of
  • implanted tibial and/or femoral components.
  • * The decision to perform a knee revision with the study device is regardless
  • of the research.
  • * Subject that is willing to give voluntary, written informed consent to
  • participate in this clinical investigation and authorize the transfer of
  • his/her information to the Sponsor
  • * Subject is currently not bedridden
  • * The devices are to be used according to the approved indications.Subject is
  • able to read, and comprehend the Informed Consent Document as well as complete
  • the required PROMs in either English or one of the available translations.

排除标准

  • * The Subject is a woman who is pregnant or lactating.
  • * Contralateral knee has already been enrolled in this study.
  • * Subject had a contralateral amputation.
  • * Subject is currently diagnosed with radicular pain from the spine that
  • radiates into the limb to receive RTKA.
  • * Subject has participated in a clinical investigation with an investigational
  • product (drug or device) in the last three (3) months.
  • * Subject is currently involved in any personal injury litigation,
  • medical-legal or worker's compensation claims.
  • * Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in
  • the last 5 years) or has a psychological disorder that could affect his/her
  • ability to complete patient reported questionnaires or be compliant with
  • follow-up requirements.
  • * Subject was diagnosed and is taking prescription medications to treat a
  • muscular disorder that limits mobility due to severe stiffness and pain such as
  • fibromyalgia or polymyalgia.
  • * Subject has a significant neurological or musculoskeletal disorder(s) or
  • disease that may adversely affect gait or weight bearing activities (e.g.,
  • muscular dystrophy, multiple sclerosis, Charcot disease).
  • * Subject has a medical condition with less than five (5) years life expectancy
  • as determined by the Investigator.
  • * Uncontrolled gout

研究者

发起方
Cturn

相似试验